"Herpes Zoster Vaccine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An attenuated vaccine used to prevent and/or treat HERPES ZOSTER, a disease caused by HUMAN HERPESVIRUS 3.
MeSH Number(s)
D20.215.894.899.290.130.400
Concept/Terms
Herpes Zoster Vaccine- Herpes Zoster Vaccine
- Vaccine, Herpes Zoster
- Zoster Vaccine
- Vaccine, Zoster
- Shingles Vaccine
- Vaccine, Shingles
Below are MeSH descriptors whose meaning is more general than "Herpes Zoster Vaccine".
Below are MeSH descriptors whose meaning is more specific than "Herpes Zoster Vaccine".
This graph shows the total number of publications written about "Herpes Zoster Vaccine" by people in Harvard Catalyst Profiles by year, and whether "Herpes Zoster Vaccine" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 2 | 0 | 2 |
| 2008 | 2 | 1 | 3 |
| 2009 | 2 | 0 | 2 |
| 2010 | 0 | 1 | 1 |
| 2013 | 3 | 0 | 3 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 1 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 1 | 2 |
| 2018 | 3 | 1 | 4 |
| 2019 | 5 | 1 | 6 |
| 2020 | 0 | 1 | 1 |
| 2021 | 2 | 0 | 2 |
| 2022 | 1 | 0 | 1 |
Below are the most recent publications written about "Herpes Zoster Vaccine" by people in Profiles.
-
Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged =19 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR Morb Mortal Wkly Rep. 2022 Jan 21; 71(3):80-84.
-
Influenza Vaccine Uptake in the Year After Concurrent vs Separate Influenza and Zoster Immunization. JAMA Netw Open. 2021 11 01; 4(11):e2135362.
-
Safety and reactogenicity of the recombinant zoster vaccine after allogeneic hematopoietic cell transplantation. Blood Adv. 2021 03 23; 5(6):1585-1593.
-
Herpes Zoster Subunit Vaccination for Renal Transplant Recipients. Clin Infect Dis. 2020 02 03; 70(4):718-719.
-
Aggregate health and economic burden of herpes zoster in the United States: illustrative example of a pain condition. Pain. 2020 02; 161(2):361-368.
-
Response to: 'Clarification regarding the statement of the association between the recombinant zoster vaccine (RZV) and gout flares' by Didierlaurent et al. Ann Rheum Dis. 2021 12; 80(12):e201.
-
Effect of Automated Immunization Registry-Based Telephonic Interventions on Adult Vaccination Rates in Community Pharmacies: A Randomized Controlled Trial. J Manag Care Spec Pharm. 2019 Sep; 25(9):989-994.
-
Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial. JAMA. 2019 07 09; 322(2):123-133.
-
Using the Self-Controlled Tree-Temporal Scan Statistic to Assess the Safety of Live Attenuated Herpes Zoster Vaccine. Am J Epidemiol. 2019 07 01; 188(7):1383-1388.
-
Immunogenicity and safety of a new live attenuated herpes zoster vaccine (NBP608) compared to Zostavax® in healthy adults aged 50 years and older. Vaccine. 2019 06 12; 37(27):3605-3610.